When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNCE - Jounce Therapeutics GAAP EPS of -$0.72 misses by $0.15
Jounce Therapeutics Inc.
Jounce Therapeutics press release (NASDAQ:JNCE): Q1 GAAP EPS of -$0.72 misses by $0.15. Gross cash burn on operating expenses and capital expenditures for the full year 2022 is expected to be approximately $115.0 million to $130.0 million. Given the strength of its balance sheet, Jounce expects its existing cash, cash equivalents and investments to be sufficient to enable the funding of its operating expenses and capital expenditure requirements through the third quarter of 2023.